SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Outlook Therapeutics Q2 Adj. EPS $(0.130) Up From $(0.580) YoY

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.130) per share. This is a 77.59 percent increase over losses of $(0.580) per share from the same period last year.

Benzinga · 05/15/2020 12:06

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.130) per share. This is a 77.59 percent increase over losses of $(0.580) per share from the same period last year.